Nuclear transcription factor Oct-1 binds to the 5′-upstream region of CYP1A1 and negatively regulates its expression

International Journal of Biochemistry and Cell Biology

Volumn 28, Issue 2, 1996, Pages 217-227

  Bhat, Rashid ^a   Weaver, James A ^a   Sterling, Kenneth M ^a,b   Bresnick, Edward ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b Tampa Bay Research Institute   (United States)

Author keywords

CYP1A1; Negative regulatory element; Oct 1; Transcription factors

Indexed keywords

CYTOCHROME P450; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; DNA BINDING; DNA FLANKING REGION; GENE EXPRESSION REGULATION; GENE TRANSFER; GENETIC ANALYSIS; HEPATOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER; NONHUMAN; PROTEIN PURIFICATION; RAT;

ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CYTOCHROME P-450 ENZYME SYSTEM; DNA-BINDING PROTEINS; DOWN-REGULATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENE EXPRESSION REGULATION; HOST CELL FACTOR C1; HUMANS; MOLECULAR SEQUENCE DATA; OCTAMER TRANSCRIPTION FACTOR-1; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RATS; REGULATORY SEQUENCES, NUCLEIC ACID; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0030068331     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/1357-2725(95)00122-0     Document Type: Article

References (42)

1. Akerblom I. E., Slater E. P., Beato M., Baxter J. P. and Mellon P. L. (1988) Negative regulation by glucocorticoids through interference with a cAMP responsive enhancer. Science 241, 350-353.
2. Ausubel F. M., Brent R., Kingston R., Moore D., Seidman J. G., Smith J. A. and Strurl K. (1992) In Current Protocols in Molecular Biology. Vol. 2, pp. 1-9. Wiley Interscience, New York.
3. Banerji J., Olson L. and Schaffner W. (1983) A lymphocyte specific cellular enhancer is located downstream of the joining region in immunoglobulin heavy chain genes. Cell 33, 729-740.
4. Bergman Y., Rice D., Grosschedle R. and Baltimore D. (1984) Two regulatory elements for immunoglobulin k light chain gene expression. Proc. Natl Acad. Sci. U.S.A. 81, 7041-7045.
5. Bohmann D., Keller W., Dale T., Scholer H. R., Tebb G. and Mattaj I. W. (1987) A transcription factor which binds to the enhancers of SV40, immunoglobulin heavy chain and U2 snRNA genes. Nature 325, 268-272.
6. Brand A. H., Micklem G. and Nasmyth K. (1987) A yeast silencer contains sequences that can promote autonomous plasmid replication and transcriptional activation. Cell 51, 709-719.
7. Braiser A. R., Täte J. E. and Habener J. F. (1989) Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines. Biotechniques 7, 1116-1122.
8. Conney A. H. (1982) Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons. Cancer Res. 42, 4875-4917.
9. Falkner F. G. and Zachau H. G. (1984) Correct transcription of an immunoglobulin k gene requires an upstream fragment containing conserved sequence elements. Nature 310, 71-74.
10. Fletcher C., Heintz N. and Roeder R. G. (1989) Purification and characterization of OTF1 a transcription factor regulating cell cycle expression of a human histone H2b gene. Cell 51, 773-781.
11. Gillette J. R., Davis D. C. and Sasame H. A. (1972) Cytochrome P-450 and its role in drug metabolism. Ann. Rev. Pharmacol. 12, 57-84.
12. Glass C. K., Hallow J. M., Devan O. V. and Rosenfeld M. G. (1988) A thyroid hormone receptor binds with opposite transcriptional effects to a common sequence motif in thyroid hormone and estrogen response elements. Cell 54, 312-323.
13. Gorman C. (1985) In DNA Cloning II: A Practical Approach (Edited by Glover D. M.), pp. 143-190. IRL Press, Oxford, U.K.
14. Gorski K., Carneiro M. and Schibler U. (1986) Tissue specific in vitro transcription from the mouse albumin promoter. Cell 47, 767-776.
15. Groves W. E., Davis F. L. and Sells B. H. (1968) Spectrophotometric determination of microgram quantities of protein without nucleic acid interference. Anal. Biochem. 21, 195-210.
16. Hay N., Takimoto M. and Bishop J. M. (1989) A fos protein is present in a complex that binds a negative regulator of myc. Genes Dev. 3, 293-330.
17. Hines R. N., Mathis J. M. and Jacob C. S. (1988) Identification of multiple regulatory elements on the human cytochrome P4501A1 gene. Carcinogenesis 9, 1599-1605.
18. Houser W. H., Cunningham C. K., Hines R. N., Schaeffer W. I. and Bresnick E. (1987) Interaction of the 4S polycyclic aromatic hydrocarbon-binding protein with the cytochrome P-450c gene. Arch. Biochem. Biophys. 259, 215-223.
19. Karol A., Lund E. and Dahlberg J. E. (1985) The two embryonic U1 RNA genes of Xenopus laevis have both common and gene specific transcription signals. EMBO J. 4, 1529-1535.
20. Kouri R. E., McKinney C. E., Slomiany D. Y., Snodgrass D. R., Wray N. P. and McLemore T. L. (1982) Positive correlation between high aryl hydrocarbon hydroxylase activity and primary lung cancer as analyzed in cryopreserved lymphocytes. Cancer Res. 42, 5030-5037.
21. Lenardo M. J., Staudt L. M., Robbins P., Kuang A., Mulligan R. and Baltimore D. (1989) Protein binding sites in Ig gene enhancers determine transcriptional activity and inducibility. Science 243, 544-546.
22. H gene promoter that includes a consensus sequence. Cell 41, 479-487.
23. Mattaj I. W., Lienhard S., Jisicny J. and DeRobertis E. M. (1985) An enhancer-like sequence within the Xenopus U2 gene promoter facilitates the formation of stable transcription complexes. Nature 316, 163-167.
24. Mizushima-Sugamo J. and Roeder R. G. (1986) Cell-type specific transcription of an immunoglobulin k light chain gene in vitro. Proc. Natl Acad. Sci. U.S.A. 83, 8511-8515.
25. Parslow T. G., Blair D. C., Murphy W. J. and Granner D. K. (1984) Structure of the 5′-ends of immunoglobin genes: a novel conserved sequence. Proc. Natl Acad. Sci. U.S.A. 81, 2650-2654.
26. Parslow T. G., Jones S. D., Bond B. and Yamamoto K. (1987) The immunoglobulin octanucleotide: independent activity and selective interaction with enhancers. Science 235, 1498-1501.
27. Paul D. and Hines R. N. (1995) In vitro binding and functional studies comparing the human CYP1A1 negative regulatory element with the orthologous sequences from rodent genes. Carcinogenesis 16, 383-392.
28. Potter H., Weir L. and Leder P. (1984) Enhancer dependent expression of human kappa immunoglobulin genes introduced in to mouse pre B-lymphocytes by electroporation. Proc. Natl Acad. Sci. U.S.A. 81, 7161-7165.
29. Pruijin G. J. M., Van Driel and Vander Vliet P. C. (1986) Nuclear factor III, a novel sequence DNA binding protein from Hela cells stimulating adenovirus DNA replication. Nature 322, 656-659.
30. Raval P., Iverson P. L. and Bresnick E. (1991) Induction of cytochrome P4501A1 and P4501A2 as determined by solution hybridization. Biochem. Pharmacol. 41, 1719-1723.
31. Sambrook J. E., Fritsch E. F. and Maniatis T. (1989) Molecular Cloning: A Laboratory Manual, pp. 16-29. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.
32. Selden R. F., Howie K. B., Rowe M. E., Goodman H. M. and Moore D. D. (1986) Human growth hormone as a reporter gene in regulation studies employing transient gene expression. Mol. Cell Biol. 6, 3173-3179.
33. Sen R. and Baltimore D. (1986) Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46, 705-716.
34. Shore D. and Nasmyth K. (1987) Purification and cloning of a DNA binding protein from yeast that binds to both silencer and activator elements. Cell 51, 721-732.
35. Singh H., Sen R., Baltimore D. and Sharp P. A. (1986) A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobin genes. Nature 319, 144-158.
36. Sive H. L. and Roeder R. G. (1986) Interaction of a common factor with conserved promoter and enhancer sequences in histone H2B, immunoglobulin and U2 small nuclear RNA (sn RNA) genes. Proc. Natl Acad. Sci. U.S.A. 83, 6382-6384.
37. Staudt L. M., Singh H., Sen R., Writh T., Sharp P. A. and Baltimore D. (1986) A lymphoid specific protein binding to the octamer motif of immunoglobin genes. Nature 323, 640-643.
38. Sterling K., Weaver J., Ho K. L., Xu L. C. and Bresnick E. (1993) RatCYP1A1 negative regulatory element: biological activity and interaction with a protein from liver and hepatoma cells. Molec. Pharmacol. 44, 560-568.
39. Sterling K. and Bresnick E. (1994) AP-1 and Oct-1 transcription factors bind to the rat CYP1A1 negative regulatory element (NRE): positive and negative regulation. Proc. Am. Assoc. Cancer Res. 35, 556.
40. Takimoto M., Quinn J. P., Farina A. R., Staudt L. M. and Levens D. C. (1989) fos/jun and octamer-binding protein interact with a common site in a negative element on the human c-myc gene. J. Biol. Chem. 264, 8992-8999.
41. Tanaka M. and Herr W. (1990) Differential transcriptional activation by Oct-1 and Oct-2: interdependent activation domains induce Oct-2 phosphorylation. Cell 60, 375-386.
42. Wides R. J., Challberg M. D., Rawlins D. R. and Kelly T. J. (1987) Adenovirus origin of DNA replication: sequence requirements for replication in vitro. Mol. Cell. Biol. 7, 875-886.